TheEdgeResearch
Home / Stocks / SNZZF

Senzime AB (publ) (SNZZF)

OTC Healthcare Medical - Devices
$0.70 ▲ +47.84%
Market Cap
$110.1M
Sector
Healthcare
Industry
Medical - Devices
Beta
0.40
52-Wk Range
0.45-0.7359
CEO
Philip Siberg
Country
SE
Currency
USD

Based in Uppsala, Sweden, Senzime AB (publ) is a medical technology company founded in 1999, specializing in the development and commercialization of advanced patient monitoring systems. These systems are designed to oversee individuals under anesthesia across a wide geographic reach, including Europe, Oceania, Asia, Canada, and the United States. A key offering is the TetraGraph monitor, which precisely stimulates, measures, analyzes, and displays muscle function for surgical patients administered neuromuscular blocking agents. The system includes the TetraSens electrode array, featuring two …

Open full interactive analysis & DCF →